Community-Based Service Use After Clozapine Treatment : A Mirror-Image Analysis of Public Claims Data
Although clozapine demonstrates unique efficacy for treatment-resistant schizophrenia, its impact on community-based services remains largely underexplored. The authors examined changes in use of community-based services after clozapine treatment among a sample of 163 patients with schizophrenia by using public claims data in Allegheny County, Pennsylvania. Mirror-image analyses of service utilization were used to compare the 180-day period before treatment initiation with the 180-day period that began after 6 months of adherent treatment, accounting for age, race, and gender. Across demographic variables, clozapine treatment was associated with increased use of community-based services and decreased use of psychiatric inpatient services (p<0.05, Bonferroni corrected), suggesting that clozapine treatment shifts service needs from emergency care to community-based care and recovery.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
Psychiatric services (Washington, D.C.) - 74(2023), 10 vom: 01. Okt., Seite 1104-1107 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sarpal, Deepak K [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 02.10.2023 Date Revised 12.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1176/appi.ps.20220471 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355215659 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355215659 | ||
| 003 | DE-627 | ||
| 005 | 20231226063859.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1176/appi.ps.20220471 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1184.xml |
| 035 | |a (DE-627)NLM355215659 | ||
| 035 | |a (NLM)37016827 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sarpal, Deepak K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Community-Based Service Use After Clozapine Treatment |b A Mirror-Image Analysis of Public Claims Data |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.10.2023 | ||
| 500 | |a Date Revised 12.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Although clozapine demonstrates unique efficacy for treatment-resistant schizophrenia, its impact on community-based services remains largely underexplored. The authors examined changes in use of community-based services after clozapine treatment among a sample of 163 patients with schizophrenia by using public claims data in Allegheny County, Pennsylvania. Mirror-image analyses of service utilization were used to compare the 180-day period before treatment initiation with the 180-day period that began after 6 months of adherent treatment, accounting for age, race, and gender. Across demographic variables, clozapine treatment was associated with increased use of community-based services and decreased use of psychiatric inpatient services (p<0.05, Bonferroni corrected), suggesting that clozapine treatment shifts service needs from emergency care to community-based care and recovery | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Clozapine | |
| 650 | 4 | |a Community residences/supported housing | |
| 650 | 4 | |a Inpatient treatmen | |
| 650 | 4 | |a Psychopharmacology/psychosocial aspects | |
| 650 | 4 | |a Rehabilitation/psychosocial | |
| 650 | 4 | |a Treatment-resistant schizophrenia | |
| 650 | 7 | |a Clozapine |2 NLM | |
| 650 | 7 | |a J60AR2IKIC |2 NLM | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 700 | 1 | |a Suh, Kangho |e verfasserin |4 aut | |
| 700 | 1 | |a Bian, Kaiqi |e verfasserin |4 aut | |
| 700 | 1 | |a Ko, Pingjui |e verfasserin |4 aut | |
| 700 | 1 | |a Gannon, Jessica M |e verfasserin |4 aut | |
| 700 | 1 | |a Jhon, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Chengappa, K N Roy |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Psychiatric services (Washington, D.C.) |d 1998 |g 74(2023), 10 vom: 01. Okt., Seite 1104-1107 |w (DE-627)NLM075107546 |x 1557-9700 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2023 |g number:10 |g day:01 |g month:10 |g pages:1104-1107 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1176/appi.ps.20220471 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2023 |e 10 |b 01 |c 10 |h 1104-1107 | ||